DurgicalDurgical
EN
Open the app

Linezolid !

An oral or IV oxazolidinone for MRSA, VRE and drug-resistant TB; watch platelets, nerves and serotonin-drug interactions.

Updated 2026-11-01

  • Class: Oxazolidinones
  • Target: Peptidyl-transferase centre of the 23S rRNA, 50S ribosomal subunit
  • ATC code: J01XX08
  • WHO Model List of Essential Medicines

The figure shows linezolid in the large (50S) ribosomal subunit of Staphylococcus aureus, a real clinical target. A structure of the human mitochondrial ribosome with linezolid also exists (PDB 9CN3) and helps explain its mitochondrial toxicity.

Target in 3D: Peptidyl-transferase centre of the 23S rRNA, 50S ribosomal subunit. PDB structure 4WFA (RCSB PDB, public domain). View the structure at RCSB PDB

Mechanism of action

Linezolid binds the 23S rRNA of the 50S subunit and stops formation of the 70S initiation complex, so translation never starts. It is bacteriostatic against staphylococci and enterococci and bactericidal for most streptococci. Resistance comes from point mutations in 23S rRNA. Mitochondrial ribosomes resemble bacterial ones, which is the likely basis of its blood, nerve and lactate toxicity.

  1. Binds the 23S rRNA of the 50S subunit
  2. The 70S initiation complex cannot form
  3. Protein synthesis never starts
  4. Growth stops (staphylococci, enterococci)

Pharmacokinetics

Absorption
Absorbed almost completely by mouth (bioavailability about 100%), so oral and IV doses are the same.
Distribution
Spreads well to well-perfused tissues; about 31% bound to plasma proteins.
Metabolism
Oxidation of its morpholine ring to two inactive metabolites, without the cytochrome P450 system.
Elimination
Mostly in the urine, as unchanged drug and its two metabolites; almost none in the faeces.

Indications

Adverse effects

Common

  • Diarrhoea, nausea, headache
  • Taste change, tongue and superficial tooth discoloration
  • Vaginal yeast infection

Contraindications

  • Hypersensitivity to linezolid
  • Current use of an MAO inhibitor, or use within the previous two weeks
  • Without blood-pressure monitoring: uncontrolled hypertension, pheochromocytoma, thyrotoxicosis or sympathomimetic drugs

Key interactions

SSRIs, SNRIs, tricyclics, triptans, buspirone, opioids such as pethidine
Serotonin syndrome (agitation, fever, sweating, clonus, rigidity); avoided or closely monitored.
Pseudoephedrine, phenylpropanolamine, vasopressors, dopaminergic drugs
Exaggerated rise in blood pressure; starting doses of adrenergic agents are reduced and titrated.
Tyramine-rich food (aged cheese, cured or fermented meat, sauerkraut, soy sauce, tap beer, red wine)
Pressor reaction with large amounts.
Insulin and oral glucose-lowering drugs
Symptomatic hypoglycaemia.
Rifampicin
Lowers linezolid exposure.

What is monitored

  • Complete blood count weekly, especially beyond two weeks or with prior cytopenias or kidney or liver disease
  • Vision (acuity and colour) and nerve symptoms in long courses
  • Signs of serotonin syndrome when combined with serotonergic drugs
  • Blood glucose in diabetics; lactate if there is unexplained nausea, vomiting or acidosis

Administration and safety

  • Oral tablets, suspension or ready-to-use IV infusion; the IV and oral routes are interchangeable.
  • Tablets and suspension can be given with or without food.
  • Before starting, the medication list is reviewed for MAO inhibitors and serotonergic or adrenergic drugs.

Nursing care

  • Baseline blood count, blood pressure and medication review (antidepressants, decongestants, MAO inhibitors).
  • Watch for bleeding, bruising or infection that may point to low blood counts.
  • Watch for agitation, fever, tremor or clonus in patients on serotonergic drugs.
  • Teaching: avoid large amounts of tyramine-rich foods; report vision change, numbness, tingling, rapid breathing or diarrhoea.

Pregnancy and breastfeeding

Published and post-marketing case reports have not identified a drug-related risk of birth defects or miscarriage; it is used in pregnancy when the benefit justifies it.

Test yourself

Think of the answer, then tap the question to see it.

A patient on sertraline starts linezolid and becomes agitated, febrile and tremulous with clonus. What is the likely diagnosis?

Serotonin syndrome: linezolid weakly inhibits MAO and adds to the serotonergic effect of the SSRI.

Which blood test is checked weekly during linezolid treatment, and why?

The complete blood count, because linezolid causes myelosuppression, especially thrombocytopenia, that grows with treatment length.

Why can linezolid be switched from IV to tablets without changing the dose?

Its oral bioavailability is about 100%, so both routes give the same exposure.

Why does linezolid not treat a gram-negative bloodstream infection?

It has no clinical activity against gram-negative pathogens; specific gram-negative therapy is needed.

Add to my cards (4)

← Back to the class: Oxazolidinones

Educational content on how drugs work; not a prescribing guide and no substitute for a health professional's advice. No doses are given.

Sources: DailyMed - LINEZOLID tablet, film coated (DailyMed (U.S. National Library of Medicine), 2026); Linezolid: MedlinePlus Drug Information (MedlinePlus (U.S. National Library of Medicine), 2026); Goodman & Gilman's The Pharmacological Basis of Therapeutics, 14th ed., ch. 60 (McGraw Hill, 2023); RCSB PDB - 4WFA: The crystal structure of the large ribosomal subunit of Staphylococcus aureus in complex with linezolid (RCSB Protein Data Bank, 2026).

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.